Team News Riveting
Rourkela, April 29
Dr. (Mrs) Pratibha Kumari Behera, Additional Chief Medical Officer (M&HS), Ispat General Hospital has brought laurels for SAIL, Rourkela Steel Plant (RSP) by bagging the “Women Trailblazer’ award under SAIL Corporate Excellence Award 2021.
She received the coveted award from Mrs. Soma Mandal, Chairman, SAIL in a glittering function organised at New Delhi on 28th April 2022. The function was attended by the esteemed members of SAIL Board including Atanu Bhowmick, Director In-charge, RSP and other Senior Officers of the Company.
Dr. Behera was awarded for playing a key role in setting up of the first Molecular Virology laboratory at IGH on 15th April 2020 when the 1st wave of Covid – 19 hit the nation. Being the 1st such lab in Western Odisha, this was a boon for the region when everyone was struggling to find ways to deal with the pandemic. She also took the lead in setting up the 2nd Molecular Virology lab in 22nd June 2021 before the third wave of Covid. Dr. Behera was also instrumental in setting up of the Plasma Bank at IGH on 31st August 2020 which was 1st in the region.
An MBBS graduate from VSS Medical College, Burla, Sambalpur, Dr. Behera joined RSP on 23rd September 1992. In 2000 she completed her MD in Pathology from MGIMS, Sevagram, Wardha, Nagpur. To further enrich herself in this field Dr. Behera did short term courses on Oncopathology from TMH, Mumbai and Fundamentals of international clinical research from NIH, New York at Bangkok. At present she is heading the Pathology Department of RSP and is also a Post Graduate teacher for DNB course.
Associated with a number of medical associations like Tropical school of London, Indian Medical Association , India, Indian Hematology & Blood Transfusion Society, India and Indian Pathology & Microbiology society, India, she has to her credit several publication both in National as well as International Journals. Her research works include Micro vascular Pathologies in Fatal adult cerebral malaria, Malaria in Pregnancy and a study by tracking resistance to Artemisinin collaboration
